Common Contracts

7 similar Joint Filing Agreement contracts by Albert & Margaret Alkek Foundation, Shapiro Gary L, Arco Capital Corp LTD, others

Joint Filing Agreement
Joint Filing Agreement • May 18th, 2015 • Shapiro Gary L • Services-prepackaged software

The undersigned hereby agree that the statements on Schedule 13D with respect to the Common Stock of Bulova Technologies Group, Inc. dated as of February 25, 2013 is, and any amendments thereto (including amendments on Schedule 13G), signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

AutoNDA by SimpleDocs
Joint Filing Agreement
Joint Filing Agreement • January 2nd, 2015 • Shapiro Gary L • Services-prepackaged software

The undersigned hereby agree that the statements on Schedule 13D with respect to the Common Stock of Bulova Technologies Group, Inc. dated as of February 25, 2013 is, and any amendments thereto (including amendments on Schedule 13G), signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

JOINT FILING AGREEMENT
Joint Filing Agreement • January 7th, 2008 • HSBC International Trustee • Services-business services, nec

The undersigned hereby agree that the Statement on Schedule 13G, dated January 7, 2008 (the “Schedule 13G”), with respect to the ordinary shares, par value $0.01 per share, of Shanda Interactive Entertainment Limited is, and any amendments executed by us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

JOINT FILING AGREEMENT
Joint Filing Agreement • October 22nd, 2007 • Neurochem Inc • Pharmaceutical preparations

We, the undersigned, agree that the attached Amendment to the Schedule 13D relating to the common stock of Neurochem Inc., is filed on behalf of each of us.

JOINT FILING AGREEMENT
Joint Filing Agreement • August 21st, 2007 • Arco Capital Corp LTD • Real estate investment trusts

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to the shares of common stock, par value $0.001 per share, of Luminent Mortgage Capital, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings.

Joint Filing Agreement
Joint Filing Agreement • April 25th, 2006 • Albert & Margaret Alkek Foundation • Pharmaceutical preparations

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.

Joint Filing Agreement
Joint Filing Agreement • April 24th, 2006 • Albert & Margaret Alkek Foundation • Pharmaceutical preparations

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!